Résultats de la recherche - 6 results

Epidemiology and genotype 3 subtype dynamics of hepatitis E virus in Belgium, 2010 to 2017.

Publication Type: Peer reviewed scientific article Authors: Suin, Vanessa; Klamer, Sofieke E; Veronik Hutse; Wautier, Magali; Jacques, Marjorie; Abady, Mona; Lamoral, Sophie; Verburgh, Vera; ...

Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.

clustered sampling. RESULTS: In total 3209 specimens, collected by 28 laboratories, were tested. HCV seropositivity in the Belgian general population was estimated to be 0.22% (95% CI: 0.09-0.54%), and prevalence of ...

Hepatitis E virus serology and PCR: does the methodology matter?

Colle, Isabelle; Veronik Hutse; Suin, Vanessa; Wautier, Magali; Steven Van Gucht; Van Vlierberghe, Hans; Padalko, Elizaveta Source: Arch Virol, Volume 162, Issue 9, p.2625-2632 (2017) Keywords: Antibodies, ...

Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

Publication Type: Peer reviewed scientific article Authors: Mesalam, Ahmed Atef; Desombere, Isabelle; Farhoudi, Ali; Van Houtte, Freya; Verhoye, Lieven; Ball, Jonathan; Dubuisson, Jean; Foung, ...

Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.

out of 30,905 patients (61.1%) in treatment for substance use disorders between 2011 and 2014 have been screened at least once for HCV between 2008 and 2015. 58.0% of those who had never injected and ...

Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method

CI 538935) for Brussels and between 6,620 (95% CI 4,7118,576) and 7,018 (95% CI 4,7949,527) for Belgium. Conclusions These estimates provide crucial information to ensure that services to PWID ...

QR code

QR code for this page URL